<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39177056</PMID><DateRevised><Year>2024</Year><Month>11</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1559-7016</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Aug</Month><Day>23</Day></PubDate></JournalIssue><Title>Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism</Title><ISOAbbreviation>J Cereb Blood Flow Metab</ISOAbbreviation></Journal><ArticleTitle>Cerebral blood flow alterations and host genetic association in individuals with long COVID: A transcriptomic-neuroimaging study.</ArticleTitle><Pagination><StartPage>271678X241277621</StartPage><MedlinePgn>271678X241277621</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">0271678X241277621</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1177/0271678X241277621</ELocationID><Abstract><AbstractText>Neuroimaging studies have indicated that altered cerebral blood flow (CBF) was associated with the long-term symptoms of postacute sequelae of SARS-CoV-2 infection (PASC), also known as "long COVID". COVID-19 and long COVID were found to be strongly associated with host gene expression. Nevertheless, the relationships between altered CBF, clinical symptoms, and gene expression in the central nervous system (CNS) remain unclear in individuals with long COVID. This study aimed to explore the genetic mechanisms of CBF abnormalities in individuals with long COVID by transcriptomic-neuroimaging spatial association. Lower CBF in the left frontal-temporal gyrus was associated with higher fatigue and worse cognition in individuals with long COVID. This CBF pattern was spatially associated with the expression of 2,178 genes, which were enriched in the molecular functions and biological pathways of COVID-19. Our study suggested that lower CBF is associated with persistent clinical symptoms in long COVID individuals, possibly as a consequence of the complex interactions among multiple COVID-19-related genes, which contributes to our understanding of the impact of adverse CNS outcomes and the trajectory of development to long COVID.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yao</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0003-2839-0824</Identifier><AffiliationInfo><Affiliation>Department of Radiology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Research Center for Medical Imaging in Jiangxi Province, Nanchang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Ziwei</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Radiology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Research Center for Medical Imaging in Jiangxi Province, Nanchang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Xiumei</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Radiology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Research Center for Medical Imaging in Jiangxi Province, Nanchang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Xiao</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Radiology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Research Center for Medical Imaging in Jiangxi Province, Nanchang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Lin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Radiology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Research Center for Medical Imaging in Jiangxi Province, Nanchang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Chengsi</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dai</LastName><ForeName>Jiankun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>MR Research, GE Healthcare, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Yuan</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-3105-7654</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry and Psychotherapy, Jena University Hospital, Jena, Germany.</Affiliation><Identifier Source="RINGGOLD">39065</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>Center for Intervention and Research on Adaptive and Maladaptive Brain Circuits Underlying Mental Health (C-I-R-C), Halle-Jena-Magdeburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Affective Neuroimaging Laboratory (CANLAB), Magdeburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Meng</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Psychotherapy, Jena University Hospital, Jena, Germany.</Affiliation><Identifier Source="RINGGOLD">39065</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>Center for Intervention and Research on Adaptive and Maladaptive Brain Circuits Underlying Mental Health (C-I-R-C), Halle-Jena-Magdeburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Affective Neuroimaging Laboratory (CANLAB), Magdeburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Fuqing</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Radiology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Research Center for Medical Imaging in Jiangxi Province, Nanchang, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cereb Blood Flow Metab</MedlineTA><NlmUniqueID>8112566</NlmUniqueID><ISSNLinking>0271-678X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Allen Human Brain Atlas</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">cerebral blood flow</Keyword><Keyword MajorTopicYN="N">gene expression</Keyword><Keyword MajorTopicYN="N">transcriptomic-neuroimaging</Keyword></KeywordList><CoiStatement>Declaration of conflicting interestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>23</Day><Hour>12</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>23</Day><Hour>12</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>23</Day><Hour>6</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39177056</ArticleId><ArticleId IdType="doi">10.1177/0271678X241277621</ArticleId><ArticleId IdType="pmc">PMC11572096</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wulf Hanson S, Abbafati C, Aerts JG, et al.. Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021. JAMA 2022; 328: 1604&#x2013;1615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9552043</ArticleId><ArticleId IdType="pubmed">36215063</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F, Ling S, Lui LMW, et al.. Fatigue and cognitive impairment in post-COVID-19 syndrome: a systematic review and meta-analysis. Brain Behav Immun 2022; 101: 93&#x2013;135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8715665</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty H, Townsend L, Morrin H, et al.. Persistent endotheliopathy in the pathogenesis of long COVID syndrome. J Thromb Haemost 2021; 19: 2546&#x2013;2553.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8420256</ArticleId><ArticleId IdType="pubmed">34375505</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahamed J, Laurence J. Long COVID endotheliopathy: hypothesized mechanisms and potential therapeutic approaches. J Clin Invest 2022; 132: e161167.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9337829</ArticleId><ArticleId IdType="pubmed">35912863</ArticleId></ArticleIdList></Reference><Reference><Citation>Libby P, L&#xfc;scher T. COVID-19 is, in the end, an endothelial disease. Eur Heart J 2020; 41: 3038&#x2013;3044.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7470753</ArticleId><ArticleId IdType="pubmed">32882706</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiao H, Deng X, Qiu L, et al.. SARS-CoV-2 induces blood-brain barrier and choroid plexus barrier impairments and vascular inflammation in mice. J Med Virol 2024; 96: e29671.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11446308</ArticleId><ArticleId IdType="pubmed">38747003</ArticleId></ArticleIdList></Reference><Reference><Citation>Greene C, Connolly R, Brennan D, et al.. Blood-brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairment. Nat Neurosci 2024; 27: 421&#x2013;432.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10917679</ArticleId><ArticleId IdType="pubmed">38388736</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva Andrade B, Siqueira S, de Assis Soares WR, et al.. Long-COVID and Post-COVID health complications: an up-to-date review on clinical conditions and their possible molecular mechanisms. Viruses 2021; 13: 13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8072585</ArticleId><ArticleId IdType="pubmed">33919537</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolai L, Kaiser R, Stark K. Thromboinflammation in long COVID-the elusive key to postinfection sequelae? J Thromb Haemost 2023; 21: 2020&#x2013;2031.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10174338</ArticleId><ArticleId IdType="pubmed">37178769</ArticleId></ArticleIdList></Reference><Reference><Citation>Wirth KJ, Scheibenbogen C, Paul F. An attempt to explain the neurological symptoms of myalgic encephalomyelitis/chronic fatigue syndrome. J Transl Med 2021; 19: 471.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8607226</ArticleId><ArticleId IdType="pubmed">34809664</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcic M, Marcic L, Lovric Kojundzic S, et al.. Chronic endothelial dysfunction after COVID-19 infection shown by transcranial color-coded doppler: a cross-sectional study. Biomedicines 2022; 10: 10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9599030</ArticleId><ArticleId IdType="pubmed">36289812</ArticleId></ArticleIdList></Reference><Reference><Citation>Petcharunpaisan S, Ramalho J, Castillo M. Arterial spin labeling in neuroimaging. World J Radiol 2010; 2: 384&#x2013;398.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2999014</ArticleId><ArticleId IdType="pubmed">21161024</ArticleId></ArticleIdList></Reference><Reference><Citation>Aj&#x10d;evi&#x107; M, Iscra K, Furlanis G, et al.. Cerebral hypoperfusion in post-COVID-19 cognitively impaired subjects revealed by arterial spin labeling MRI. Sci Rep 2023; 13: 5808.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10086005</ArticleId><ArticleId IdType="pubmed">37037833</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim WSH, Ji X, Roudaia E, et al.. MRI assessment of cerebral blood flow in nonhospitalized adults who self-isolated due to COVID-19. J Magn Reson Imaging 2023; 58: 593&#x2013;602.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9877942</ArticleId><ArticleId IdType="pubmed">36472248</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin Y, Wu J, Chen T, et al.. Long-term microstructure and cerebral blood flow changes in patients recovered from COVID-19 without neurological manifestations. J Clin Invest 2021; 131</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8262559</ArticleId><ArticleId IdType="pubmed">33630760</ArticleId></ArticleIdList></Reference><Reference><Citation>Sen S, Newman-Norlund R, Riccardi N, et al.. Cerebral blood flow in patients recovered from mild COVID-19. J Neuroimaging 2023; 33: 764&#x2013;772.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11205277</ArticleId><ArticleId IdType="pubmed">37265421</ArticleId></ArticleIdList></Reference><Reference><Citation>Initiative C-HG. Mapping the human genetic architecture of COVID-19. Nature 2021; 600: 472&#x2013;477.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8674144</ArticleId><ArticleId IdType="pubmed">34237774</ArticleId></ArticleIdList></Reference><Reference><Citation>Pairo-Castineira E, Clohisey S, Klaric L, et al.. Genetic mechanisms of critical illness in COVID-19. Nature 2021; 591: 92&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pubmed">33307546</ArticleId></ArticleIdList></Reference><Reference><Citation>Initiative C-HG. A first update on mapping the human genetic architecture of COVID-19. Nature 2022; 608: E1&#x2013;e10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9352569</ArticleId><ArticleId IdType="pubmed">35922517</ArticleId></ArticleIdList></Reference><Reference><Citation>Initiative C-HG. A second update on mapping the human genetic architecture of COVID-19. Nature 2023; 621: E7&#x2013;e26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10482689</ArticleId><ArticleId IdType="pubmed">37674002</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu D, Zhao R, Yuan H, et al.. Host genetic factors, comorbidities and the risk of severe COVID-19. J Epidemiol Glob Health 2023; 13: 279&#x2013;291.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10169198</ArticleId><ArticleId IdType="pubmed">37160831</ArticleId></ArticleIdList></Reference><Reference><Citation>Udomsinprasert W, Nontawong N, Saengsiwaritt W, et al.. Host genetic polymorphisms involved in long-term symptoms of COVID-19. Emerg Microbes Infect 2023; 12: 2239952.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10392286</ArticleId><ArticleId IdType="pubmed">37497655</ArticleId></ArticleIdList></Reference><Reference><Citation>Scialo F, Daniele A, Amato F, et al.. ACE2: the major cell entry receptor for SARS-CoV-2. Lung 2020; 198: 867&#x2013;877.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7653219</ArticleId><ArticleId IdType="pubmed">33170317</ArticleId></ArticleIdList></Reference><Reference><Citation>Lukiw WJ, Pogue A, Hill JM. SARS-CoV-2 infectivity and neurological targets in the brain. Cell Mol Neurobiol 2022; 42: 217&#x2013;224.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7445393</ArticleId><ArticleId IdType="pubmed">32840758</ArticleId></ArticleIdList></Reference><Reference><Citation>McCracken IR, Saginc G, He L, et al.. Lack of evidence of angiotensin-converting enzyme 2 expression and replicative infection by SARS-CoV-2 in human endothelial cells. Circulation 2021; 143: 865&#x2013;868.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7899720</ArticleId><ArticleId IdType="pubmed">33405941</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang RC, Huang K, Zhang HP, et al.. SARS-CoV-2 productively infects human brain microvascular endothelial cells. J Neuroinflammation 2022; 19: 149.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9198209</ArticleId><ArticleId IdType="pubmed">35705998</ArticleId></ArticleIdList></Reference><Reference><Citation>Claassen J, Thijssen DHJ, Panerai RB, et al.. Regulation of cerebral blood flow in humans: physiology and clinical implications of autoregulation. Physiol Rev 2021; 101: 1487&#x2013;1559.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8576366</ArticleId><ArticleId IdType="pubmed">33769101</ArticleId></ArticleIdList></Reference><Reference><Citation>Goel P, Kuceyeski A, LoCastro E, et al.. Spatial patterns of genome-wide expression profiles reflect anatomic and fiber connectivity architecture of healthy human brain. Hum Brain Mapp 2014; 35: 4204&#x2013;4218.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4283562</ArticleId><ArticleId IdType="pubmed">24677576</ArticleId></ArticleIdList></Reference><Reference><Citation>Richiardi J, Altmann A, Milazzo AC, et al.. BRAIN NETWORKS. Correlated gene expression supports synchronous activity in brain networks. Science 2015; 348: 1241&#x2013;1244.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4829082</ArticleId><ArticleId IdType="pubmed">26068849</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan SE, Seidlitz J, Whitaker KJ, et al.. Cortical patterning of abnormal morphometric similarity in psychosis is associated with brain expression of schizophrenia-related genes. Proc Natl Acad Sci U S A 2019; 116: 9604&#x2013;9609.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6511038</ArticleId><ArticleId IdType="pubmed">31004051</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Gao W, Cao W, et al.. Cortical thickness alterations are associated with astrocytes and excitatory neuron-specific transcriptome signatures in pediatric bipolar disorder. Cereb Cortex 2023; 33: 7540&#x2013;7552.</Citation><ArticleIdList><ArticleId IdType="pubmed">36928535</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun J, Xie Y, Wang Q, et al.. Genes associated with grey matter volume reduction in multiple sclerosis. J Neurol 2022; 269: 2004&#x2013;2015.</Citation><ArticleIdList><ArticleId IdType="pubmed">34455470</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnatkeviciute A, Fulcher BD, Fornito A. A practical guide to linking brain-wide gene expression and neuroimaging data. NeuroImage 2019; 189: 353&#x2013;367.</Citation><ArticleIdList><ArticleId IdType="pubmed">30648605</ArticleId></ArticleIdList></Reference><Reference><Citation>Long J, Li J, Xie B, et al.. Morphometric similarity network alterations in COVID-19 survivors correlate with behavioral features and transcriptional signatures. NeuroImage Clin 2023; 39: 103498.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10474075</ArticleId><ArticleId IdType="pubmed">37643521</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikram MA, Zonneveld HI, Roshchupkin G, et al.. Heritability and genome-wide associations studies of cerebral blood flow in the general population. J Cereb Blood Flow Metab 2018; 38: 1598&#x2013;1608.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6120124</ArticleId><ArticleId IdType="pubmed">28627999</ArticleId></ArticleIdList></Reference><Reference><Citation>Excellence NIfHaC. National institute for health and care excellence: Clinical guidelines. COVID-19 rapid guideline: managing the long-term effects of COVID-19. London: National Institute for Health and Care Excellence (NICE), 2020.</Citation></Reference><Reference><Citation>Ambarki K, W&#xe5;hlin A, Zarrinkoob L, et al.. Accuracy of parenchymal cerebral blood flow measurements using pseudocontinuous arterial spin-labeling in healthy volunteers. AJNR Am J Neuroradiol 2015; 36: 1816&#x2013;1821.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7965027</ArticleId><ArticleId IdType="pubmed">26251434</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherman BT, Hao M, Qiu J, et al.. DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update). Nucleic Acids Res 2022; 50: W216&#x2013;W221.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9252805</ArticleId><ArticleId IdType="pubmed">35325185</ArticleId></ArticleIdList></Reference><Reference><Citation>Dougherty JD, Schmidt EF, Nakajima M, et al.. Analytical approaches to RNA profiling data for the identification of genes enriched in specific cells. Nucleic Acids Res 2010; 38: 4218&#x2013;4230.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2910036</ArticleId><ArticleId IdType="pubmed">20308160</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu X, Wells AB, O&#x2019;Brien DR, et al.. Cell type-specific expression analysis to identify putative cellular mechanisms for neurogenetic disorders. J Neurosci 2014; 34: 1420&#x2013;1431.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3898298</ArticleId><ArticleId IdType="pubmed">24453331</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon DE, Jang GM, Bouhaddou M, et al.. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature 2020; 583: 459&#x2013;468.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7431030</ArticleId><ArticleId IdType="pubmed">32353859</ArticleId></ArticleIdList></Reference><Reference><Citation>Ardellier FD, Baloglu S, Sokolska M, SFNR-COVID group et al.. Cerebral perfusion using ASL in patients with COVID-19 and neurological manifestations: a retrospective multicenter observational study. J Neuroradiol 2023; 50: 470&#x2013;481.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9842391</ArticleId><ArticleId IdType="pubmed">36657613</ArticleId></ArticleIdList></Reference><Reference><Citation>Antony AR, Haneef Z. Systematic review of EEG findings in 617 patients diagnosed with COVID-19. Seizure 2020; 83: 234&#x2013;241.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7569418</ArticleId><ArticleId IdType="pubmed">33121875</ArticleId></ArticleIdList></Reference><Reference><Citation>Kas A, Soret M, Pyatigoskaya N, et al.. The cerebral network of COVID-19-related encephalopathy: a longitudinal voxel-based 18F-FDG-PET study. Eur J Nucl Med Mol Imaging 2021; 48: 2543&#x2013;2557.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7810428</ArticleId><ArticleId IdType="pubmed">33452633</ArticleId></ArticleIdList></Reference><Reference><Citation>Goehringer F, Bruyere A, Doyen M, et al.. Brain (18)F-FDG PET imaging in outpatients with post-COVID-19 conditions: findings and associations with clinical characteristics. Eur J Nucl Med Mol Imaging 2023; 50: 1084&#x2013;1089.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9628394</ArticleId><ArticleId IdType="pubmed">36322190</ArticleId></ArticleIdList></Reference><Reference><Citation>Matschke J, L&#xfc;tgehetmann M, Hagel C, et al.. Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol 2020; 19: 919&#x2013;929.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7535629</ArticleId><ArticleId IdType="pubmed">33031735</ArticleId></ArticleIdList></Reference><Reference><Citation>Gagliardi S, Poloni ET, Pandini C, et al.. Detection of SARS-CoV-2 genome and whole transcriptome sequencing in frontal cortex of COVID-19 patients. Brain Behav Immun 2021; 97: 13&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8132498</ArticleId><ArticleId IdType="pubmed">34022369</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou S, Wei T, Liu X, et al.. Causal effects of COVID-19 on structural changes in specific brain regions: a mendelian randomization study. BMC Med 2023; 21: 261.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10354891</ArticleId><ArticleId IdType="pubmed">37468885</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh KK, Chaubey G, Chen JY, et al.. Decoding SARS-CoV-2 hijacking of host mitochondria in COVID-19 pathogenesis. Am J Physiol Cell Physiol 2020; 319: C258&#x2013;C267.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7381712</ArticleId><ArticleId IdType="pubmed">32510973</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumari D, Singh Y, Singh S, et al.. Mitochondrial pathogenic mutations and metabolic alterations associated with COVID-19 disease severity. J Med Virol 2023; 95: e28553.</Citation><ArticleIdList><ArticleId IdType="pubmed">36832542</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaundal RK, Kalvala AK, Kumar A. Neurological implications of COVID-19: Role of redox imbalance and mitochondrial dysfunction. Mol Neurobiol 2021; 58: 4575&#x2013;4587.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8190166</ArticleId><ArticleId IdType="pubmed">34110602</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefano GB, Ptacek R, Ptackova H, et al.. Selective neuronal mitochondrial targeting in SARS-CoV-2 infection affects cognitive processes to induce &#x2018;brain fog&#x2019; and results in behavioral changes that favor viral survival. Med Sci Monit 2021; 27: e930886.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7845145</ArticleId><ArticleId IdType="pubmed">33487628</ArticleId></ArticleIdList></Reference><Reference><Citation>Artusi CA, Romagnolo A, Ledda C, et al.. COVID-19 and Parkinson&#x2019;s disease: What do We know so far? J Parkinsons Dis 2021; 11: 445&#x2013;454.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8150504</ArticleId><ArticleId IdType="pubmed">33749619</ArticleId></ArticleIdList></Reference><Reference><Citation>Salari M, Etemadifar M, Ashrafi F, et al.. Parkinson&#x2019;s disease patients may have higher rates of covid-19 mortality in Iran. Parkinsonism Relat Disord 2021; 89: 90&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8264275</ArticleId><ArticleId IdType="pubmed">34256334</ArticleId></ArticleIdList></Reference><Reference><Citation>Smadi M, Kaburis M, Schnapper Y, et al.. SARS-CoV-2 susceptibility and COVID-19 illness course and outcome in people with pre-existing neurodegenerative disorders: systematic review with frequentist and bayesian meta-analyses. Br J Psychiatry 2023; 223: 348&#x2013;361.</Citation><ArticleIdList><ArticleId IdType="pubmed">37183681</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C, Liu J, Lin J, et al.. COVID-19 and risk of neurodegenerative disorders: a mendelian randomization study. Transl Psychiatry 2022; 12: 283.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9281279</ArticleId><ArticleId IdType="pubmed">35835752</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao H, Zhang Q, Chen H, et al.. Integrated multi-omics approach identified molecular mechanism and pathogenetic processes of COVID-19 that affect patient with parkinson&#x2019;s disorder. Saudi J Biol Sci 2021; 28: 6939&#x2013;6945.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8327558</ArticleId><ArticleId IdType="pubmed">34366686</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Arrigo JS. Nanotargeting of drug(s) for delaying dementia: Relevance of covid-19 impact on dementia. Am J Alzheimers Dis Other Demen 2020; 35: 1533317520976761.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10623919</ArticleId><ArticleId IdType="pubmed">33307726</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y, Liu W, Yang Y, et al.. Exploration of the shared molecular mechanisms between COVID-19 and neurodegenerative diseases through bioinformatic analysis. Int J Mol Sci 2023; 24: 24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10002862</ArticleId><ArticleId IdType="pubmed">36902271</ArticleId></ArticleIdList></Reference><Reference><Citation>Zorec R, Verkhratsky A. Astrocytes in the pathophysiology of neuroinfection. Essays Biochem 2023; 67: 131&#x2013;145.</Citation><ArticleIdList><ArticleId IdType="pubmed">36562155</ArticleId></ArticleIdList></Reference><Reference><Citation>Steardo L, Steardo L, Jr., Zorec R, et al.. Neuroinfection may contribute to pathophysiology and clinical manifestations of COVID-19. Acta Physiol (Oxf) 2020; 229: e13473.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7228251</ArticleId><ArticleId IdType="pubmed">32223077</ArticleId></ArticleIdList></Reference><Reference><Citation>Murta V, Villarreal A, Ramos AJ. Severe acute respiratory syndrome coronavirus 2 impact on the Central nervous system: Are astrocytes and microglia main players or merely bystanders? ASN Neuro 2020; 12: 1759091420954960.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7476346</ArticleId><ArticleId IdType="pubmed">32878468</ArticleId></ArticleIdList></Reference><Reference><Citation>Bark L, Larsson IM, Wallin E, et al.. Central nervous system biomarkers GFAp and NfL associate with post-acute cognitive impairment and fatigue following critical COVID-19. Sci Rep 2023; 13: 13144.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10423244</ArticleId><ArticleId IdType="pubmed">37573366</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-Casta&#xf1;eda A, Lu P, Geraghty AC, et al.. Mild respiratory SARS-CoV-2 infection can cause multi-lineage cellular dysregulation and myelin loss in the brain. bioRxiv 2022;</Citation></Reference><Reference><Citation>Karsidag S, Sahin S, Ates MF, et al.. Demyelinating disease of the Central nervous system concurrent with COVID-19. Cureus 2021; 13: e17297.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8449512</ArticleId><ArticleId IdType="pubmed">34552833</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>